Fennec Pharmaceuticals Inc.

(FRX:PUR)

By |

Profile

Fennec Pharmaceuticals Inc is a small stage biotechnology company. The Company is engaged in the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.

Contact Information

Website: www.fennecpharma.com
Email: adherex@adherex.com
Main Phone: +1 919 636-4530
Address: 68 TW Alexander Drive
Address 2: PO Box 13628
State: NC
City / Town: Research Triangle Park
Country: USA
Postal Code: 27709

Issuer Information

Exchange: TSX
Employees: 3
NAICS: Pharmaceutical P
$ 15.19 $ 0. (0.00%)
Last Price 15.19 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 15.19
Last Trade Volume 0 52 Wk Hi 15.20 52 Wk Low 7.46
Market Cap 240.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 15,856,738.00 EPS (TTM) -0.29 PE Ratio N/A Exchange TSX
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 2